Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples

References

• D'Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012; 26: 1287–99.
   Google Scholar
• Taylor DD, Gercel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer. 2005; 92: 305–11. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cai J, Han Y, Ren H, Chen C, He D, Zhou L, etal. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol. 2013; 5: 227–38.
   Google Scholar
• Choi DS, Kim DK, Kim YK, Gho YS. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics. 2013; 13: 1554–71.
   Google Scholar
• Inal JM, Fairbrother U, Heugh S. Microvesiculation and disease. Biochem Soc Trans. 2013; 41: 237–40.
   Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010; 73: 1907–20.
   Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200: 373–83.
   Google Scholar
• Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011; 3: 15.
   Google Scholar
• Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015; 25: 364–72.
   Google Scholar
• Camussi G, Deregibus MC, Tetta C. Tumor-derived microvesicles and the cancer microenvironment. Curr Mol Med. 2013; 13: 58–67.
   Google Scholar
• Kucharzewska P, Belting M. Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles. 2013; 2: 20304. http://dx.doi.org/10.3402/jev.v2i0.20304.
   Google Scholar
• An T, Qin S, Xu Y, Tang Y, Huang Y, Situ B, etal. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles. 2015; 4: 27522. http://dx.doi.org/10.3402/jev.v4.27522 [PubMed Abstract].
   Google Scholar
• Tatischeff I. Cell-derived extracellular vesicles open new perspectives for cancer research. Cancer Res Front. 2015; 1: 208–24.
   Google Scholar
• Webber J, Yeung V, Clayton A. Extracellular vesicles as modulators of the cancer microenvironment. Sem Cell Dev Biol. 2015; 27–34.
   Google Scholar
• Nicholas J. A new diagnostic tool with the potential to predict tumor metastasis. J Natl Cancer Inst. 2013; 105: 371–2.
   Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Cancer J Clin. 2014; 64: 9–29.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Secreto CR, Knox TR, Ding W, Mukhopadhyay D, Kay NE. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood. 2010; 115: 1755–64.
   Google Scholar
• Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 2003; 21: 841–94.
   Google Scholar
• Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Durig J, etal. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med. 2012; 209: 2183–98.
   Google Scholar
• Belov L, Mulligan SP, Barber N, Woolfson A, Scott M, Stoner K, etal. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br J Haematol. 2006; 135: 184–97.
   Google Scholar
• Ellmark P, Belov L, Huang P, Lee CS, Solomon MJ, Morgan DK, etal. Multiplex detection of surface molecules on colorectal cancers. Proteomics. 2006; 6: 1791–802.
   Google Scholar
• Kaufman KL, Belov L, Huang P, Mactier S, Scolyer RA, Mann GJ, etal. An extended antibody microarray for surface profiling metastatic melanoma. J Immunol Methods. 2010; 358: 23–34.
   Google Scholar
• Zhou J, Belov L, Huang PY, Shin JS, Solomon MJ, Chapuis PH, etal. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. J Immunol Methods. 2010; 355: 40–51.
   Google Scholar
• Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, Wang A, etal. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci USA. 2015; 112: E1433–42. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, etal. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014; 3: 26913. http://dx.doi.org/10.3402/jev.v3.26913.
   Google Scholar
• Oksvold MP, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, etal. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther. 2014; 36: 847–62 e1.
   Google Scholar
• Saunderson SC, Schuberth PC, Dunn AC, Miller L, Hock BD, MacKay PA, etal. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol. 2008; 180: 8146–52.
   Google Scholar
• Whitehead RH, Macrae FA, John DJBS, Ma J. A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. J Natl Cancer Inst. 1985; 74: 759–65. [PubMed Abstract].
   Google Scholar
• Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D, etal. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res. 1999; 23: 127–36.
   Google Scholar
• Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M, etal. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009; 4: 5219. http://dx.doi.org/10.1371/journal.pone.0005219.
   Google Scholar
• Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006. Chapter 3:Unit 3.22, doi: http://dx.doi.org/10.1002/0471143030.
   Google Scholar
• Colino J, Snapper CM. Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice. Infect Immun. 2007; 75: 220–30.
   Google Scholar
• Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, etal. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012; 2012: 971907.
   Google Scholar
• Li J, Lee Y, Johansson HJ, Mager I, Vader P, Nordin JZ, etal. Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles. J Extracell Vesicles. 2015; 4: 26883. http://dx.doi.org/10.3402/jev.v4.26883 [PubMed Abstract].
   Google Scholar
• Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, etal. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood. 2008; 111: 5446–56.
   Google Scholar
• Belov L, Huang P, Barber N, Mulligan SP, Christopherson RI. Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics. 2003; 3: 2147–54.
   Google Scholar
• Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 2001; 61: 4483–9. [PubMed Abstract].
   Google Scholar
• Ellmark P, Woolfson A, Belov L, Christopherson RI. The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human disease. Methods Mol Biol. 2008; 439: 199–209. [PubMed Abstract].
   Google Scholar
• Hamelinck D, Zhou H, Li L, Verweij C, Dillon D, Feng Z, etal. Optimized normalization for antibody microarrays and application to serum-protein profiling. Mol Cell Proteomics. 2005; 4: 773–84.
   Google Scholar
• Zhou J, Belov L, Armstrong N, Christopherson RI. Antibody microarrays and multiplexing. Bioinform Hum Proteomics. 2013; 3: 331–59.
   Google Scholar
• Sedlmayr P, Leitner V, Pilz S, Wintersteiger R, Stewart CC, Dohr G. Species-specific blocking of Fc-receptors in indirect immunofluorescence assays. Laboratory Hematol. 2001; 7: 81–4.
   Google Scholar
• Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, etal. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost. 2012; 10: 437–46.
   Google Scholar
• Mullier F, Bailly N, Chatelain C, Chatelain B, Dogne JM. Pre-analytical issues in the measurement of circulating microparticles: recommendations and pending questions. J Thromb Haemost. 2013; 11: 693–6.
   Google Scholar
• Gardiner C, Ferreira YJ, Dragovic RA, Redman CW, Sargent IL. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles. 2013; 2: 19671. http://dx.doi.org/10.3402/jev.v2i0.19671.
   Google Scholar
• Huang PY, Kohnke P, Belov L, Best OG, Mulligan SP, Christopherson RI. Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes. J Pharm Pharm Sci. 2013; 16: 231–7. [PubMed Abstract].
   Google Scholar
• Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, etal. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica. 2011; 96: 277–83.
   Google Scholar
• Dürig J, Naschar M, Schmücker U, Renzing-Köhler K, Hölter T, Hüttmann A, etal. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia. 2002; 16: 30–5.
   PubMed Web of Science ®Google Scholar
• Zhou J, Belov L, Solomon MJ, Chan C, Clarke SJ, Christopherson RI. Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing. J Vis Exp. 2011; 55: 3322. http://dx.doi.org/10.3791/3322 [PubMed Abstract].
   Google Scholar
• de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, etal. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles. 2012; 1: 18396. http://dx.doi.org/10.3402/jev.v1i0.18396.
   Google Scholar
• Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998; 273: 20121–7.
   Google Scholar
• Ji H, Greening DW, Barnes TW, Lim JW, Tauro BJ, Rai A, etal. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics. 2013; 13: 1672–86.
   Google Scholar
• Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, etal. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010; 70: 1668–78.
   Google Scholar
• Perez-Hernandez D, Gutierrez-Vazquez C, Jorge I, Lopez-Martin S, Ursa A, Sanchez-Madrid F, etal. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem. 2013; 288: 11649–61.
   Google Scholar
• Greening DW, Ji H, Kapp EA, Simpson RJ. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis. Biochim Biophys Acta. 2013; 1834: 2293–307.
   Google Scholar
• Gutierrez LS. The role of thrombospondin 1 on intestinal inflammation and carcinogenesis. Biomark Insights. 2008; 3: 171–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown SJ, Lo PH, etal. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget. 2014; 5: 5782–97.
   Google Scholar
• Miyata Y, Sakai H. Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci. 2013; 14: 12249–72.
   Google Scholar
• Sutton CD, O'Byrne K, Goddard JC, Marshall LJ, Jones L, Garcea G, etal. Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis. Clin Cancer Res. 2005; 11: 6567–73.
   Google Scholar
• Niederfellner G, Lammens A, Mundigl O, Georges GJ, Schaefer W, Schwaiger M, etal. Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. Blood. 2011; 118: 219–20.
   Web of Science ®Google Scholar
• Haderk F, Hanna B, Richter K, Schnolzer M, Zenz T, Stilgenbauer S, etal. Extracellular vesicles in chronic lymphocytic leukemia. Leuk Lymphoma. 2013; 54: 1826–30.
   Google Scholar
• Paggetti J, Haderk F, Seiffert M, Janji B, Kim YJ, Diestler U, etal. Chronic lymphocytic leukemia-exosomes switch endothelial and mesenchymal stroma cells into cancer-associated fibroblasts to sustain leukemic cell survival. Blood. 2014; 124: 2927.
   Web of Science ®Google Scholar
• Burgess M, Gill D, Singhania R, Cheung C, Chambers L, Renyolds BA, etal. CD62L as a therapeutic target in chronic lymphocytic leukemia. Clin Cancer Res. 2013; 19: 5675–85.
   Google Scholar
• Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Bulian P, etal. Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance. J Transl Med. 2006; 4: 11.
   Google Scholar
• Vlad A, Deglesne P-A, Letestu R, Saint-Georges S, Chevallier N, Baran-Marszak F, etal. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease. Cancer Res. 2009; 69: 6387–95.
   Google Scholar
• Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, etal. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med. 2014; 371: 213–23.
   Google Scholar
• Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P, etal. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014; 370: 997–1007.
   Google Scholar
• Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, etal. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci USA. 2011; 108: 15336–41.
   Google Scholar
• Paggetti J, Haderk F, Seiffert M, Janji B, Distler U, Ammerlaan W, etal. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015; 126: 1106–17.
   Google Scholar
• Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, etal. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biol. 2015; 1–14.
   Google Scholar
• Jakobsen KR, Paulsen BS, Bæk R, Varming K, Sorensen BS, Jørgensen MM. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracell Vesicles. 2015; 4: 26659. http://dx.doi.org/10.3402/jev.v4.26659 [PubMed Abstract].
   Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost. 2007; 5: 520–7.
   Google Scholar
• Moreno A, Lucena C, Lopez A, Garrido JJ, Perez de la Lastra JM, Llanes D. Immunohistochemical analysis of ß3 integrin (CD61): expression in pig tissues and human tumors. Histol Histopathol. 2002; 17: 347–52.
   Web of Science ®Google Scholar
• Saalbach A, Wetzel A, Haustein U-F, Sticherling M, Simon JC, Anderegg U. Interaction of human Thy-1 (CD 90) with the integrin αvβ3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. Oncogene. 2005; 24: 4710–20.
   Google Scholar
• Seurynck-Servoss SL, White AM, Baird CL, Rodland KD, Zangar RC. Evaluation of surface chemistries for antibody microarrays. Anal Biochem. 2007; 371: 105–15.
   Google Scholar
• Hong CS, Muller L, Boyiadzis M, Whiteside TL. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One. 2014; 9: 103310. http://dx.doi.org/10.1371/journal.pone.0103310.
   Google Scholar
• Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, etal. Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. Oncotarget. 2015; 6: 15375.
   Google Scholar